July 1, 2014, Austin, TX – Inova Labs Inc. (“Inova Labs”), a leading manufacturer of innovative oxygen therapy solutions has received FDA-clearance for Activox DUO2™, the first fully-integrated stationary and portable oxygen concentrator system. Activox DUO2™ combines the benefits of a home-use stationary concentrator with the portability of a best-in-class LifeChoice Activox POC into one integrated system. This unique combination provides active oxygen therapy to patients with a no compromises solution that is ready to go when they are.
Activox DUO2™ offers up to 5 LPM continuous flow oxygen for patients at home and up to 3 LPMeq PULSE-WAVE™ oxygen delivery for active patients out of the home using the POC. With the LifeChoice Activox POC, patients can enjoy up to 12.5 hours of internal battery life while away from home. When it is time to recharge, simply connect the POC to the stationary base. The stationary base can recharge both the internal and external batteries of the POC.
Activox DUO2™ is an integrated system which includes data reporting capabilities to improve service and system monitoring. A retractable handle and locking wheels make it easy to transport from room to room, while simple controls allow for easy set up and operation.
“Activox DUO2™ was designed to provide patients and providers with a non-delivery solution that can positively impact both quality of life and quality of service,” commented John Rush, CEO. “This system removes the hassle and burden of tanks and replaces it with true freedom and mobility, which we believe is imperative to improving an oxygen patient’s life.”
The Activox DUO2™ Oxygen System will be available in the upcoming months.
Inova Labs Inc. is a medical device company specializing in the development and commercialization of innovative products for patients with respiratory conditions. Product offerings include the FDA-cleared LifeChoice Activox™ and Activox DUO2™ oxygen concentrators. www.InovaLabs.com.